Ebola doctors
Heroic efforts admired
Angels of mercy!
Genome sequencing
Compare normal with patient
Secrets revealed
Next-gen sequencing
One big issue still out there
Interpretation
Republicans rule
Eye Affordable Care Act
Newly covered screwed?
2.3 percent
Medical devices tax
Soon to disappear?
Advertised widely
Personalized medicine
More substance, less hype
Sovaldi pricing
Gilead raked over coals
Stock climbed; profits soared
Drug pricing pushback
Express Scripts draws line in sand
Game-changing response
Tax inversions slow
AbbVie rejects Irish move
Shire pockets big bucks
Surrogate markers
Big focus in the clinic
Numbers meaningful?
Dendreon bankrupt
Valeant bought its assets
Will Provenge survive?
Dissed for many years
Immunotherapy hailed!
How much will it cost?
Big patent battle
Immunotherapy field
Settlement was reached
Brain tumor patients
Want to die on your own terms?
Move to Oregon
More vaccines needed
Chikungunya virus spreads
Now in the U.S.
Biosimilars
Embroiled in naming debate
Lawyers pockets filled
Question for the Court
Off-label drug promotion
Selling or free speech?
Venture capital
Spending like drunken sailors
Hope they chose wisely
Drug prices soaring
Charging what market will bear
No link to “value”
Who is disliked more?
Insurance firms, Big Pharma?
Brought this on themselves
Big Data love-fest
Nuggets buried within it
Mining will be tough
Watson fights cancer
Bested all on Jeopardy
New task much harder
Cancer drug pricing
Forcing docs to hospitals
Effect on patients?
Amgen Seattle
Closed by the lords in T.O.
Job cuts raise stock price
Helix campus fate?
Expedia’s new HQ
Selling trips, not drugs
Processed foods harmful
Obesity crisis cause?
Sugar, fat, and salt
GSK China
Big fines paid for bribery
Which country is next?
PCSK9
Inhibiting this target
Drops cholesterol
The debate rages on
Big Pharma “innovation”
Discover or buy?
Healthcare system flawed
Changes would cut players income
Lobbyists block change
Remicade challenged
Biosimilar sales soar!
Low price in Norway
Obesity rising
Followed by diabetes
Huge healthcare problem
STEM education
More science in the classroom
Not Kardashians
World’s richest nation
Our health care stats more third world
Past time to fix this
Click here to read my previous collection of biopharmaceutical haiku.
